Literature DB >> 8968873

Rapid susceptibility testing of fungi by flow cytometry using vital staining.

C Wenisch1, K F Linnau, B Parschalk, K Zedtwitz-Liebenstein, A Georgopoulos.   

Abstract

A 1-h assay for antifungal susceptibility testing measuring the impairment of fungal metabolic activity was developed. Yeast viability was analyzed by flow cytometry with a novel fluorescent probe, FUN-1, which emits a red fluorescence when the yeast is metabolically active. For nine Candida albicans strains tested, this method yielded results comparable to those obtained by the standard M27 procedure for amphotericin B, flucytosine, fluconazole, and ketoconazole. Whether the flow cytometry antifungal susceptibility test results correlate with the in vivo activities of the drugs remains to determined.

Entities:  

Mesh:

Year:  1997        PMID: 8968873      PMCID: PMC229504          DOI: 10.1128/jcm.35.1.5-10.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  The use of flow cytometry to monitor chitin synthesis in regenerating protoplasts of Candida albicans.

Authors:  R F Hector; P C Braun; J T Hart; M E Kamarck
Journal:  J Med Vet Mycol       Date:  1990

2.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

3.  Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods.

Authors:  J N Galgiani; J Reiser; C Brass; A Espinel-Ingroff; M A Gordon; T M Kerkering
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 4.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

5.  Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.

Authors:  R L Stiller; J E Bennett; H J Scholer; M Wall; A Polak; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

6.  Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.

Authors:  C R Horsburgh; C H Kirkpatrick
Journal:  Am J Med       Date:  1983-01-24       Impact factor: 4.965

7.  Amphotericin B susceptibility testing of Candida species by flow cytometry.

Authors:  M R O'Gorman; R L Hopfer
Journal:  Cytometry       Date:  1991

8.  Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.

Authors:  D L Calhoun; G D Roberts; J N Galgiani; J E Bennett; D S Feingold; J Jorgensen; G S Kobayashi; S Shadomy
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

Review 9.  Emerging fungal pathogens.

Authors:  E J Anaissie; G P Bodey; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

10.  Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance.

Authors:  W G Merz
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

View more
  18 in total

1.  Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay.

Authors:  K A Marr; M Koudadoust; M Black; S A Balajee
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome.

Authors:  C Wenisch; C B Moore; R Krause; E Presterl; P Pichna; D W Denning
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 3.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Rapid flow cytometric susceptibility testing of Candida albicans.

Authors:  R Ramani; A Ramani; S J Wong
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

5.  Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing of Candida albicans.

Authors:  Vishnu Chaturvedi; Rama Ramani; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Flow cytometry susceptibility testing for the antifungal caspofungin.

Authors:  M Mitchell; M Hudspeth; A Wright
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test.

Authors:  R Ramani; V Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

8.  Characteristics and dynamics of bacterial populations during postantibiotic effect determined by flow cytometry.

Authors:  M Gottfredsson; H Erlendsdóttir; A Sigfússon; S Gudmundsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

9.  Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.

Authors:  Cidália Pina-Vaz; Sofia Costa-de-Oliveira; Acácio G Rodrigues; Ana Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 10.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.